Faculty of Dentistry Ain Shams University
Cairo, 11361, Egypt
Location status: Recruiting
Location contact
Marwa El Kassaby
CONTACT
NCT Number: NCT06513039
regenerative materials would help in decreasing post-extraction resorption in sites indicated for placement of a conventional bridge or prosthetically driven implant. Erythropoietin (EPO) is a growth factor that promotes angiogenesis and bone regeneration by stimulating osteoblastic differentiation and by inhibiting osteoclastic resorption. Post-extraction alveolar ridge resorption creates morphological and volumetric changes. These changes can be considered of clinical value that may threaten the placement of a conventional bridge or an implant-supported crown. Atwood et al. [1] in a cephalometric study categorized factors influencing the rate of alveolar ridge resorption into 4 types: anatomic, metabolic, functional, and prosthetic. As stated by Tan et al. [2] in a systematic review of alveolar hard and soft tissue dimensional changes in humans post-extraction, they found that alveolar ridge resorption occurs to a greater extent in a horizontal direction than vertical. Therefore, alveolar ridge preservation (ARP) procedures were introduced in an attempt to prevent hard and soft tissue dimensional changes following extraction.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Phase 4
Cairo, 11361, Egypt
Location status: Recruiting
Marwa El Kassaby
CONTACT
II. Aim of the study:
To assess the efficiency of Erythropoietin in alveolar ridge preservation.
Primary objective:
Dimensional changes of the ridge clinically and radiographically.
Secondary objective:
III. Materials and Methods
It is a randomized controlled clinical trial. Patients will be selected from the outpatient clinic of the Department of Oral Medicine and Periodontology-Ain Shams University and the British University of Egypt. All patients will sign an informed consent about the details of the surgery according to the Ethical Committee Ain Shams University.
The sample size was estimated based on assuming confidence level= 95% and study power= 80%. Pandya et al. [29] reported that the Collagen percentage was 2.1%±0.6% in EPO treated sockets while it was 1%±0.6% in non-treated sockets, the average Standard deviation was 0.6%n. The minimum sample size was calculated to be 5 extraction sockets per group. This was increased to 7 sockets to make up for lost to follow-up cases. The total sample size = number of groups × number per group= 3×7= 21 sockets. The sample size was collected by G power 3.0.10.
Inclusion criteria
Exclusion criteria
Pre-surgical phase:
Patients will be initially examined. All patients will receive oral hygiene instructions using roll technique with a soft-bristled toothbrush and interdental floss, and phase I therapy using an ultrasonic device if necessary. At baseline, intraoral periapical radiographs, clinical periodontal measurements including plaque Index [38] , bleeding on probing (BOP) [38], probing depth (PD) [38], and clinical attachment level (CAL) [38] will be recorded at teeth adjacent to the extraction socket area using a UNC periodontal probe [38].
Impressions will be taken using Alginate impression material before the extraction day. Diagnostic casts will be made for the fabrication of a customized stent to standardize the measurements of marginal crestal bone levels at baseline and 4 months post-extraction [39].
Surgical preparation of Extraction socket:
Group II: extraction sockets filled with CS/ β-GP/gelatin hydrogels alone until the crestal level.
Group III: Natural healing socket (control group).
Implant placement Surgery
Patients will return for a follow-up examination at 4 months and implant placement.
Postoperative care instruction and medication of both surgeries:
A) Clinical assessment:
B) Radiographic assessment:
Dimensional changes will be measured using Cone Beam computed Tomography (CBCT) at baseline immediately following tooth extraction and 4 months postoperatively [42].
C) Histomorphometric assessment:
Histological and histomorphometric assessment of bone regeneration patterns of core biopsy harvested at the re-entry surgery for implant placement 4 months post extraction using H&E stains to evaluate bone trabeculae and Modified Masson Trichrome to evaluate bone maturity[46].
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient will have extraction of teeth and placement of Erythropoietin carried on chitosan carrier for six months to enhance bone healing
inert scaffold agent
Time frame: six months
Clinical measurement using bone caliper. Radiographic measurement using CBCT
Time frame: six months
Visual analogue scale.
Contact information is provided by the study sponsor or research team.
Ain Shams University
Other
Evaluation of Erythropoietin on Alveolar Ridge Preservation: (A Randomized Controlled Clinical Trial With Histomorphometric Assessment)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718932
Alveolar Bone Loss, Bone Diseases
Thessaloniki, Greece
View Trial DetailsNCT07669792
Alveolar Bone Loss, Bone Diseases
Cairo, Egypt
View Trial DetailsNCT07433322
Alveolar Bone Loss, Bone Diseases
Richmond, Virginia, United States
View Trial DetailsNCT07638319
Alveolar Bone Grafting, Alveolar Bone Loss
Caparica, Monte Da Caparica, Portugal
View Trial Details